The objective of this systematic review was to evaluate which salivary biomarkers are
altered in patients with burning mouth syndrome (BMS) compared to a control group (CG). A …

Mitochondrial homeostasis is crucial for energy production and neuronal survival in
neurological primary burning mouth syndrome (npBMS). Photobiomodulation therapy …

Background Some studies have shown burning mouth syndrome (BMS) as comorbid
psychosocial and psychiatric disorders, and as well, pointed at stress as a major risk factor …

Ocular discomfort and eye pain are frequently reported by patients with dry eye disease
(DED), and their management remains a real therapeutic challenge for the Ophthalmologist …

Objectives To investigate frequency of single nucleotide polymorphisms (SNPs) in pain‐
related temporomandibular disorders (TMDp) and to determine whether specific SNPs …

Melatonin's role in circadian rhythm is well documented, as are its' anti-oxidant, oncostatic
and anti-inflammatory properties. Poor sleep quality has been associated as a potential risk …

Objectives Opiorphin is a recently discovered peptide shown to inhibit the enkephalin-
degrading enzymes and prolong the effects of enkephalins. Although opiorphin is found in …

Burning mouth syndrome (BMS) is a neuropathic pain disorder associated with a burning
sensation on oral mucosal surfaces with frequently reported xerostomia, dysgeusia and …

Background. The use of easily accessible biomarkers for assessing young patients' health is
weighty. This cohort study is aimed at measuring stress/immune biomarkers in the saliva of …

Purpose: Opiorphin is an endogenous inhibitor of enkephalin-degrading enzymes. It has a
strong analgesic effect in chemical and mechanical pain models. We aimed to evaluate the …